FSTL5 and hepatocellular carcinoma: In summary, we found that FSTL5 was downregulated in HCC cell and HCC tissue and FSTL5 expression positively correlated with good prognosis in patients with HCC at TNM stages I/II rather than TNM stage III/IV.